1. Home
  2. TECX vs USBC Comparison

TECX vs USBC Comparison

Compare TECX & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • USBC
  • Stock Information
  • Founded
  • TECX 2019
  • USBC N/A
  • Country
  • TECX United States
  • USBC
  • Employees
  • TECX N/A
  • USBC 6
  • Industry
  • TECX
  • USBC
  • Sector
  • TECX
  • USBC
  • Exchange
  • TECX Nasdaq
  • USBC Nasdaq
  • Market Cap
  • TECX 387.1M
  • USBC 317.2M
  • IPO Year
  • TECX 2018
  • USBC N/A
  • Fundamental
  • Price
  • TECX $19.02
  • USBC $0.88
  • Analyst Decision
  • TECX Buy
  • USBC
  • Analyst Count
  • TECX 6
  • USBC 0
  • Target Price
  • TECX $79.17
  • USBC N/A
  • AVG Volume (30 Days)
  • TECX 515.4K
  • USBC N/A
  • Earning Date
  • TECX 11-06-2025
  • USBC N/A
  • Dividend Yield
  • TECX N/A
  • USBC N/A
  • EPS Growth
  • TECX N/A
  • USBC N/A
  • EPS
  • TECX N/A
  • USBC N/A
  • Revenue
  • TECX N/A
  • USBC N/A
  • Revenue This Year
  • TECX N/A
  • USBC N/A
  • Revenue Next Year
  • TECX N/A
  • USBC N/A
  • P/E Ratio
  • TECX N/A
  • USBC N/A
  • Revenue Growth
  • TECX N/A
  • USBC N/A
  • 52 Week Low
  • TECX $13.70
  • USBC N/A
  • 52 Week High
  • TECX $61.07
  • USBC N/A
  • Technical
  • Relative Strength Index (RSI)
  • TECX 61.68
  • USBC 40.55
  • Support Level
  • TECX $16.98
  • USBC $0.77
  • Resistance Level
  • TECX $18.77
  • USBC $1.21
  • Average True Range (ATR)
  • TECX 1.30
  • USBC 0.11
  • MACD
  • TECX 0.54
  • USBC -0.02
  • Stochastic Oscillator
  • TECX 96.12
  • USBC 20.22

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About USBC USBC Inc. Common Stock

USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.

Share on Social Networks: